NWR Weekly Wrap ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­    ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­  
View in browser
014fff0e-d808-e0aa-0213-b29ea5eed130
d2952fcd-676e-04c2-f6d2-5d736ee49fa3

Perseus Mining (ASX: PRU) added to its portfolio this week, taking a 9.9% interest in West African gold explorer Aurum Resources (ASX: AUE) via a $23.7 million cornerstone investment in Aurum’s A$28.8 million strategic placement at A$0.60 per share. The placement lifts Aurum’s pro forma cash position to more than A$60 million, strengthening its ability to execute 130,000m of drilling across its Boundiali and Napié gold projects and deliver the Boundiali PFS in April 2026 and a DFS later in the year. The investment highlights strong strategic alignment with Perseus, whose nearby operations in Côte d’Ivoire present potential synergies as Aurum progresses toward development. Covered by The Sydney Morning Herald.

 

Sparc Technologies (ASX: SPN) shares surged more than 42% following news of a collaboration with HydroGraph Clean Power, a North American graphene producer with a market capitalisation of ~A$2.9 billion. The agreement provides access to HydroGraph’s fractal graphene for use in Sparc’s ecosparc® coating additives, with early testwork showing positive results and further ISO-standard corrosion testing underway. Subject to successful outcomes, the parties are targeting a commercial supply agreement within ~12 months, supporting continued momentum following Sparc’s first ecosparc® revenues in late 2025. Covered by SmallCaps.

 

Condor Energy (ASX: CND) accelerated technical studies across its TEA-86 licence area in the offshore Tumbes Basin, Peru, and has identified large-scale deepwater fan reservoir systems comparable to those hosting major discoveries in Namibia, Guyana, Suriname and Angola. The integrated geological and geophysical work has addressed a key exploration risk ahead of schedule, supporting progression toward an exploration Licence Contract conversion application and establishing a clear pathway toward drilling exploration wells.

 

Kalamazoo Resources (ASX: KZR) presented at the Gold Coast Gold conference, highlighting progress at its Ashburton Gold Project in WA, including initial assay results from Phase 1 growth drilling and the commencement of ~14,000m resource infill drilling at the Mt Olympus deposit. Results from five of the eight drill holes returned two intervals of greater than 45 gram metres, while the infill program is focused on increasing confidence in the Mt Olympus resource model. Following the drill results, Petra Capital released an updated research note on Kalamazoo with a price target of $0.73/share. Covered by The West Australian and Mining.com.au. 


Atomic Eagle (ASX: AEU) CEO Phil Hoskins and Lotus Resources (ASX: LOT) Managing Director Greg Bittar presented at Shaw and Partners’ 8th Uranium Conference this week.

Weekly Wrap section dividers (1200 × 180px) (4)

We’re hosting the second installment of our Critical Minerals Webinar on Wednesday, 1 April 2026 at 1:00pm (AEDT), bringing together a strong line up of ASX-listed companies including 

American Tungsten & Antimony (ASX: AT4); Brazilian Critical Minerals (ASX: BCM);  

Charger Metals (ASX: CHR); Turnstone Resources (ASX: TSR); Heavy Rare Earths (ASX: HRE);  Koba Resources (ASX: KOB); Power Minerals (ASX:PNN) and European Resources (ASX: ERE).

 

Register to attend: https://lnkd.in/gj6CfxeM

Screenshot 2026-03-26 140628
Copy of Copy of 2 Weekly Wrap section dividers (1200 × 180px) (14)

NWR hosted a two-day Virtual Healthcare Conference this week in conjunction with the Bioshares Biotech Summit. Thanks to all those companies who participated. Replays are now available below.

 

Radiopharm Theranostics (ASX: RAD) Replay
Paradigm Biopharmaceuticals (ASX: PAR) Replay

Bioxyne (ASX: BXN) Replay

Chimeric Therapeutics (ASX: CHM) Replay & PDF Presentation

ImmVirX (private) Replay

Avecho Biotechnology (ASX: AVE) Replay

Emyria (ASX: EMD) Replay

Alterity Therapeutics (ASX: ATH) Replay

Neurotech International (ASX: NTI) Replay 

Syntara (ASX: SNT) Replay

EMVision (ASX: EMV) Replay

Filamon (Private) Replay

Nexalis Therapeutics (ASX: NX1) Replay

Saluda Medical (ASX: SLD) Replay

Vitrafy Life Sciences (ASX: VFY) Replay

Firebrick Pharma (ASX: FRE) Replay

PainChek (ASX: PCK) Replay

Tetratherix (ASX: TTX) Replay

ReNerve (ASX: RNV) Replay 

ECS Botanics (ASX: ECS) Replay

Bio-Gene Technology (ASX: BGT) Replay

AnteoTech (ASX: ADO) Replay & PDF Presentation

InteliCare (ASX: ICR) Replay

CurveBeam AI (ASX: CVB) Replay

    vantage point

    Vantage Point’s latest guest is Saluda Medical (ASX: SLD) CEO Barry Regan, showcasing a company that spent 15 years developing a spinal cord stimulation device that is the first of its kind. Traditional spinal cord stimulation (SCS) delivers a fixed dose of electrical stimulation regardless of what a patient's body is doing — sitting, sleeping, walking. The nervous system changes constantly but the traditional device didn't respond to this.

     

    Saluda was founded in Sydney in 2010 by the former CTO of Cochlear, drawing directly on the philosophy behind the bionic ear — sense first, then respond. The result is Evoke: a closed-loop SCS system, FDA-approved for chronic pain. Evoke fires a stimulation pulse, measures the nerve's electrical response in real time, and adjusts the next pulse within milliseconds. Every patient. Every movement.

     

    The episode covers:

    • Why Cochlear DNA runs through everything Saluda built
    • The clinical case: superior pain outcomes, reduced opioid usage, fewer device replacements
    • How >280 issued patents create a moat that Boston Scientific and Medtronic can't easily compress
    • A US$23B market that's been dramatically undersolved — and why Evoke changes the maths
    • The journey from Sydney lab to FDA approval to ASX listing
    • What Saluda looks like when it wins at scale.

    Spotify | YouTube

    thumbnailify.com_youtube_thumbnail_Full_HD_2026-03-26_03-11-59
    464b3264-700d-c512-d21d-1015cfbda0fa

    Petra Capital rated Element 25 (ASX: E25) a BUY with a $1.73 price target, implying ~458% upside to the share price of $0.31 when released. Petra highlighted the company’s progress toward expansion at its 100%-owned, fully permitted Butcherbird Manganese Project, with engineering work advancing, long lead items being ordered and key contracts under negotiation. Subject to funding and a final investment decision, E25 is targeting first production in March 2027.

     

    Euroz Hartleys maintained a Speculative Buy on EQ Resources (ASX: EQR) and increased its price target to $0.53 (from $0.41), implying ~83% upside to the share price of $0.29 at the time of publication. Euroz highlighted continued strength in tungsten prices, with spot pricing of ~US$2,500–2,800/mtu reflecting a tight global market and supply constraints, alongside EQR’s position as a producing tungsten exposure outside China. At current spot prices, Euroz estimates EQR could generate ~A$450m in annualised free cash flow from the June quarter, supported by production from Mt Carbine (Australia) and Saloro (Spain). Subject to operational execution and market conditions, Euroz forecasts group production of ~185k mtu in FY26, increasing to ~304k mtu in FY27.

     

    GBA Capital released a desk note on Emryia (ASX: EMD) following news it will deliver its first Victorian-based Empax clinic next quarter, expanding its capacity to deliver reimbursable, evidence-based mental health treatments. GBA said this materially reduced EMD's execution risk as it transitions to a revenue phase and was a key step in its national rollout strategy.

    1d8e370b-b352-ca8f-385a-25e59f5d215f

    METALS, MINING AND ENERGY

     

    Auric Mining (ASX: AWJ) completed all gold sales from the Munda Gold Mine Starter Pit in WA, with bullion achieving an average price of A$7,178 per ounce. Net cash and the sole debtor total A$43.5 million (excluding GST).  A total of 8,886 ounces were produced from the Munda Starter Pit - 46% above budget. Performance across production, grade, and recovery further reinforces Munda’s status as a significant gold resource.  Covered by Mining.com.au,  Sydney Morning Herald, Mining Monthly & MiningNews.net.

     

    Sunshine Metals (ASX: SHN) was awarded a $202,235 Queensland Government CEI grant to fund diamond drilling at the Trooper Creek Au Ag Cu Zn target near Charters Towers, with a 650m hole planned to test a coincident chargeability and conductivity anomaly interpreted as potential subsurface sulphide mineralisation. The target remains undrilled, although historical drilling 1.5km along strike returned 6m at 1.35g/t Au, supporting prospectivity. Drilling is scheduled to commence in June 2026 as Sunshine continues to advance regional exploration alongside development activities at Liontown and Sybil. Covered by Mining.com.au and Australian Resources & Investment.

     

    Native Mineral Resources (ASX: NMR) completed a 560oz gold doré pour at its Blackjack Processing Plant, with Podosky on track for first blast on 7 April 2026 ahead of mining commencing. Drilling at Podosky is complete, pit design is finalised, and ore haulage to Blackjack is scheduled to commence mid-April. NMR holds exclusive mining rights at Podosky for 12 months, with multiple parallel workstreams advancing across its Charters Towers and Ravenswood assets in northern Queensland.

     

    Charger Metals (ASX:CHR) reported initial drill results from its Lake Johnston Lithium & Gold Project, with 3,418 m completed this quarter. These RC results has identified new spodumene-pegmatite lodes in the Medcalf hanging wall including: 11 m @ 0.81% Li₂O & 164 ppm Ta from 116 m, and 2 m @ 1.33% Li₂O & 61 ppm Ta from 131 m. Following the receipt of all assay results over the coming weeks, Medcalf Lithium Resource will be revised from its current 8.2Mt @ 1.0% Li20. Covered by MiddleNews.

     

    Power Minerals (ASX: PNN) executed a non-binding term sheet with Summit Nanotech subsidiary Summit Explore to develop its Salta Lithium Project in Argentina, covering five lithium brine salares and targeting potential for the world’s first multi-salar lithium operation. Under the proposed structure, Explore can earn a 59% joint venture interest by funding and developing a 5,000t DLE plant, with up to US$6 million committed to exploration and studies, alongside an option to acquire the project outright for US$50 million. The agreement supports development using Summit’s denaLi DLE technology, designed to deliver high recovery and low impurity lithium production. Covered by Stockhead.

     

    Desert Metals (ASX: DM1) commenced a Phase 1, 40-hole, ~2,000m aircore drilling program at the Tiogo gold prospect in Côte d’Ivoire, targeting a 900m untested mineralised corridor between previous high grade intercepts of 12m at 4.20g/t gold and 8m at 6.47g/t gold. The program is designed to follow up these results and test coincident geophysical and soil anomalies within a broader +4km mineralised trend, with drilling expected to be completed within two weeks and first assay results anticipated in April 2026. Covered by The Market Bull.

     

    Golden Dragon Mining (ASX: GDR) announced the completion of an independent exploration target and prospectivity review by Kevin Cassidy from Bare Rock Geoscience, over Golden Dragon’s greater Cue Gold Project, situated in the Murchison Goldfields in Western Australia, generating multiple highly ranked exploration targets.

     

    Alice Queen (ASX: AQX) identified a new high-grade gold target at its Viani Project in Fiji, with recent trench results highlighting strong mineralisation and reinforcing the scale potential of the system. High-grade gold results over 40m of strike returned from three parallel trenches include 4m @ 10.91 g/t Au and 2m @ 13.69 g/t Au. Mineralisation has now been defined over a ~5km strike and remaining open along strike and at depth. Covered by Mining.com.au.

     

    Strata Minerals (ASX: SMX) launched its Phase 2 drilling program at the Zelica Gold Project in WA, following strong results from its maiden drill campaign. The planned reverse circulation (RC) program will include approximately 20 holes for around 2,500 metres. The focus will be on step-out drilling to test depth extensions of the high-grade gold mineralisation identified to date, supported by targeted infill drilling aimed at accelerating the delivery of a maiden Mineral Resource Estimate. Covered by Stockhead.

     

    Many Peaks Minerals (ASX: MPK) completed compilation and field validation of historical datasets for the Ferké South Project in Côte d’Ivoire, including mapping, soil geochemistry, rock chip sampling, and shallow reconnaissance RC drilling. The historical data confirms a coherent gold system extending into Ferké South, more than doubling the strike length of the Leraba Gold Corridor to 37km.

     

    Premier 1 (ASX: PLC) completed a high-resolution gravity survey at the Rochefort Gold Prospect, Abbotts North in WA’s Murchison region. Results confirmed gold mineralisation aligns with multiple major structural intersections, supported by soil and high-grade rock chip data.

     

    Drilling commenced at the Postman’s Gully Prospect at Koonenberry Gold’s (ASX: KNB) Enmore Project in NSW, representing the company’s first test of the highly prospective Borah Fault, a parallel regional scale structure to the Sunnyside Shear Zone. Results are anticipated in May. Covered by Stockhead.

     

    Middle Island Resources (ASX: MDI) kicked off the 2026 exploration at its Bobija Project in Serbia. Phase 2 drilling is targeting extensions of high-grade gold, silver, base metals & barite at Bobija Mine, while soil sampling at Tisovik aims to expand large silver-lead-zinc-antimony anomalies across a 5km strike.

     

    Heavy Rare Earths (ASX: HRE) confirmed significant mineralogical discoveries at its Radium Hill Project in South Australia, with collaborative research confirming the presence of monazite and xenotime  -  two highly sought-after rare earth element host minerals previously unrecognised in the area. Covered by Stockhead.

     

    Andean Silver (ASX: ASL) joined VanEck Junior Gold Miners ETF, known globally as the GDXJ, effective from market open on 23 March 2026. View the company’s latest investor presentation here.


    Ragnar Metals (ASX: RAG) provided an exploration update for the Harnäs Project in Sweden, where recent channel sampling within the historic pit has returned high-grade gold over variable widths, confirming extensions to the known mineralised veins. In parallel, the Company has received the necessary drill permits enabling commencement of drill planning and the rig is currently mobilising to site. These results further strengthen Ragnar’s confidence in the district-scale potential at Harnäs and support the Company’s strategy to rapidly advance the project through systematic drilling.

     

    RENEWABLE ENERGY

     

    Sparc Technologies (ASX: SPN) signed a Letter of Intent with HydroGraph Clean Power Inc. to evaluate the incorporation of HydroGraph's Fractal Graphene into Sparc's ecosparc® additives for protective coatings. The agreement follows successful water-based coating tests showing positive performance benefits, with ISO 12944 cyclic corrosion testing in solvent-based coatings now planned. Subject to successful outcomes, the parties will negotiate a definitive commercial supply and collaboration agreement within approximately 12 months. Covered by SmallCaps.


    Hazer Group (ASX: HZR) engaged global engineering firm KBR to fast-track development of its clean hydrogen project with FortisBC Energy Inc. in British Columbia, Canada. KBR will leverage its existing understanding of the Hazer process to expedite site-specific engineering, refine project economics and assess economies of scale for the planned 2,500 tonne per annum commercial facility. Covered by Fuel Cell work and H2 View.

     

    BIOTECH

     

    Radiopharm Theranostics (ASX: RAD) announced the second interim data from 20 patients in its U.S. Phase 2b clinical imaging trial of RAD 101 in brain metastases. RAD 101 is Radiopharm’s novel, small-molecule imaging agent targeting fatty acid synthase (FASN) and radiolabelled with Fluorine-18 for the diagnosis of suspected recurrent brain metastases from solid tumors of different origins. The analysis showed that 90% (18/20) of the patients dosed with RAD101 achieved concordance between PET imaging and MRI (the primary endpoint). 

     

    Emyria (ASX: EMD) provided an update on the progress of its first Victorian-based Empax clinic with patient treatments on target to commence in Q2 CY2026. This clinic represents a significant step in Emyria’s national rollout strategy and is expected to expand the Company’s capacity to deliver reimbursable, evidence-based mental health treatments. Covered by Stockhead.

     

    Paradigm Biopharmaceuticals (ASX: PAR) announced the activation of an additional

    international clinical trial site in Hong Kong for its global Phase 3 clinical study evaluating injectable pentosan polysulfate sodium (iPPS) in patients with knee osteoarthritis.


    PainChek (ASX: PCK) reported strong quarterly growth in the UK aged care market, with 4,000 new contracted licenses providing 9% quarter on quarter growth and an additional $230,000 AUD ARR once implemented. Total UK global licenses and ARR will be reported in the upcoming quarterly business update post March 31st 2026.

     

    CORPORATE NEWS

     

    Richmond Vanadium Technology (ASX: RVT) approved the relocation of its corporate and administrative base to Brisbane, aligning executive leadership with advancement of the Richmond–Julia Creek Project through BFS, EIS and Mining Lease Application approvals. The move aims to strengthen engagement with Queensland regulators and stakeholders, improve coordination of permitting and development activities, and streamline corporate functions, while WA project activities will be supported by local teams.

     

    Sparc Technologies (ASX: SPN) received a $680,000 non-dilutive R&D advance from Rockford Equity Pty Ltd, drawn against a portion of its expected FY26 R&D tax refund. The funding will support ongoing ecosparc® commercialisation activities and the Sparc Hydrogen joint venture.

     

    Turnstone Resources (ASX: TSR) formerly South Harz, commenced trading under its new name, reflecting its transition to a multi-asset critical minerals strategy. TSR has expanded into Sweden, securing an option over the Glava 100 Cu-Au-Ag Project and being granted six exploration licences across the highly prospective Värmland copper-gold belt. A maiden drilling programme at the Glava-Klinten and Torsby West Projects is planned for mid-2026.

    2bd5880e-8827-b5ce-6048-53977a37b835

    Could this new cannabis oil be a global first for treating autism? Neurotech International (ASX: NTI) featured in media coverage by the Herald Sun; Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial coverage by Cannabiz.

     

    Existing myleofibrosis drugs can make the condition worse but Syntara Ltd (ASX: SNT) could be about to change that - media coverage by Market Link.

     

    FiveRock Asset Management “The Olympic tailwind driving 4 of our Top 10 holdings” Why we are overweight Queensland Small Caps as the Sunshine State gets ready for 2032… Media coverage by LiveWire Markets.

     

    Locksley Resources (ASX: LKS) Launches maiden drilling in California - Media coverage by Mining.com.au.

    9360579f-5f37-12bd-5e32-0b822a6998a0

    Kalamazoo Resources (ASX: KZR) Investor Presentation

     

    Sunshine Metals (ASX: SHN) Investor Presentation

     

    Tarrina Resources (ASX: TR8) Investor Presentation

     

    North Stawell Minerals (ASX: NSM) Investor Presentation

    08d61125-922d-f279-49d0-ba04b9faa6bb
    thumbnailify.com_youtube_thumbnail_Full_HD_2026-03-26_03-20-12

    Kairos Minerals (ASX: KAI) Managing Director Dr Peter Turner spoke to MiningNews’ Ngaire McDiarmid following the MiningNews Select Sydney Conference to provide an update on the upcoming Mineral Resource Estimate for KAI’s Mt York Gold Project in WA.

    thumbnailify.com_youtube_thumbnail_Full_HD_2026-03-26_03-20-37

    Kalamazoo Resources (ASX: KZR) Executive Director Ben Ackerman spoke to Mining.com.au from the Ashburton Gold Project site in WA’s Pilbara.

    NWR Communications, Level 6, 350 Collins Street, Melbourne, VIC 3000

    Unsubscribe Manage preferences